BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16190566)

  • 21. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial dysfunction in cirrhosis.
    Iwakiri Y; Groszmann RJ
    J Hepatol; 2007 May; 46(5):927-34. PubMed ID: 17391799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
    Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
    Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural course and physiopathology of ascites in the cirrhotic patient].
    Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.
    Wiest R; Jurzik L; Herold T; Straub RH; Schölmerich J
    Peptides; 2007 Feb; 28(2):396-404. PubMed ID: 17194504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of portal hypertensive gastropathy: an unresolved issue.
    Lo GH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1482-3. PubMed ID: 19743994
    [No Abstract]   [Full Text] [Related]  

  • 31. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
    Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
    Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
    J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E; Ilan Y; Shoval D
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
    Michielsen PP; Pelckmans PA
    Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E; Ginès P
    Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.